| 注册
首页|期刊导航|中国临床药理学杂志|巴曲酶联合银杏达莫注射液治疗突发性耳聋的临床疗效及安全性评价

巴曲酶联合银杏达莫注射液治疗突发性耳聋的临床疗效及安全性评价

李淦峰 李志海

中国临床药理学杂志2016,Vol.32Issue(8):675-677,3.
中国临床药理学杂志2016,Vol.32Issue(8):675-677,3.DOI:10.13699/j.cnki.1001-6821.2016.08.001

巴曲酶联合银杏达莫注射液治疗突发性耳聋的临床疗效及安全性评价

Clinical efficacy and safety of batroxobin combined with gingko injection in the treatment of sudden deafness

李淦峰 1李志海2

作者信息

  • 1. 杭州市萧山区第一人民医院 耳鼻喉科,杭州 311200
  • 2. 台州市中心医院耳鼻咽喉科,浙江台州 318000
  • 折叠

摘要

Abstract

Objective To evaluate the clinical efficacy and safety of ba-troxobin combined with gingko injection in the treatment of sudden deaf-ness.Methods A total of 118 patients with sudden deafness were ran-domly divided into control group ( n =59 ) and treatment group ( n=59 ) .Control group was received batroxobin 10 BU +0.9%NaCl 100 mL, every other day.Treatment group was given 5%glucose 10-25 mL +gingko injection 15 mL, twice a day, on the basis of control group.The course of treatment for two groups was 10 d.The clinical efficacy, fibri-nogen levels,hemodynamics, blood coagulation, and the incidence of ad-verse drug reactions were compared between two groups.Results After treatment, total effective rate in treatment group was significantly higher than that in control group (93.22%vs 83.05%, P<0.05).After treat-ment, the fibrinogen levels, blood rheology and coagulation of the two groups were better than those before treatment with significant difference ( P<0.05) , and the degree of improvement in treatment group were sig-nificantly better than that in control group ( P<0.05 ) .The incidence of adverse drug reactions of control group and treatment grou were 5.08%, 10.07%, respectively without statistically significant difference ( P>0.05).&nbsp;The recovery time of adverse drug reactions of treatment group was shorter than that of control group with statistically significant difference ( P<0.05 ) .Conclusion Batroxobin combined with ginkgo injection has a definitive clinical efficacy for the treatment of sudden deafness, it can significantly reduce fibrinogen levels, improve hemodynamics and blood coagulation, without increasing the incidence of adverse drug reactions.

关键词

巴曲酶/银杏达莫注射液/突发性耳聋/纤维蛋白原/临床疗效/安全性

Key words

batroxobin/gingko injection/sudden deafness/fibrinogen/clinical efficacy/safety

分类

医药卫生

引用本文复制引用

李淦峰,李志海..巴曲酶联合银杏达莫注射液治疗突发性耳聋的临床疗效及安全性评价[J].中国临床药理学杂志,2016,32(8):675-677,3.

基金项目

浙江省医药卫生科技计划项目基金资助项目 ()

中国临床药理学杂志

OA北大核心CSCDCSTPCD

1001-6821

访问量2
|
下载量0
段落导航相关论文